Low expression level of PPM1H is associated with worse outcomes in hepatocellular carcinoma, colorectal cancer, and pancreatic cancer (Iyer et al., 2023; Xu et al., 2019; Zhu et al., 2016). Here, PPM1H is linked to familial pancreatic carcinoma.